Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Lodo locks down Hibiskus

The MSU cancer drug spinout has been acquired on the strength of its expertise in proteasome inhibitors and preclinical pipeline.


Sep 14, 2020

Codiak comes back for second IPO attempt

Exosome therapy developer Codiak Biosciences – based on research at Gothenburg and MD Anderson Cancer Center – has filed to raise up to $100m.

Sep 11, 2020

Daily deal net: September 11, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 11, 2020

UTokyo takes Bird Initiative under its wing

UTokyo Innovation Fund has signed up to a new incubator that will form companies commercialising university-industry collaborations.

Sep 11, 2020

PolyTech picks up Fos4X

TU Munich's wind farm IoT spinout Fos4X has been acquired by PolyTech, providing an exit tothe university's venture capital affiliate UVC Partners.

Sep 11, 2020

Korro Bio surges to $91.5m series A

Wu Capital has led a series A round for Korro Bio, whose RNA editing technology was developed at UChicago-affiliated Marine Biological Laboratory.

Sep 11, 2020

Satt Paris-Saclay sets course with more cash

The French government has released an additional $21.5m in funding to the tech transfer office, which concurrently restructured its shareholding structure.

Sep 11, 2020

Omnitracs to take SmartDrive in $450m deal

Stanford University is set to exit video telematics system developer SmartDrive, which has agreed to be purchased after raising at least $265m.

Sep 10, 2020

Recursion takes $239m funding excursion

University of Utah's drug discovery technology producer has raised series D funding to increase its post-money valuation to some $1.2bn.

Sep 10, 2020

Michigan spawns 31 spinouts in 2019-20

U-M Tech Transfer generated a record number of spinouts for a second consecutive year but reported less funding for its portfolio.

Sep 10, 2020

Everactive motions for more series C funding

Fluke has added to $30m of series C capital raised by University of Michigan and Virginia-founded Everactive last year.

Sep 10, 2020

PMV veers toward $100m IPO

PMV Pharmaceuticals – built on foundational work at Princeton – will use some of the proceeds to complete phase 1 trials of its lead asset.

Sep 10, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here